ETN-103

N/A

Report date: 2024/05/27 17:07:02
NME

Base Information

Drug NameETN-103
Drug Alias NameETN-103ETN103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeurodegenerative DiseasesBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEtnova Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A